Glucagon receptor antagonists, preparation and therapeutic uses

Details for Australian Patent Application No. 2006341392 (hide)

Owner Eli Lilly and Company

Inventors Conner, Scott Eugene; Zhu, Guoxin; Hipskind, Philip Arthur; Lamar, Jason Eric; Chappell, Mark Donald

Agent Spruson & Ferguson

Pub. Number AU-B-2006341392

PCT Pub. Number WO2007/114855

Priority 60/737,979 18.11.05 US

Filing date 10 November 2006

Wipo publication date 11 October 2007

Acceptance publication date 17 May 2012

International Classifications

C07C 235/42 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61K 31/4412 (2006.01) - having oxo groups directly attached to the heterocyclic ring

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 213/10 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Event Publications

22 May 2008 PCT application entered the National Phase

  PCT publication WO2007/114855 Priority application(s): WO2007/114855

17 May 2012 Application Accepted

  Published as AU-B-2006341392

13 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006341398-IL-21 receptor antagonists

2006341380-Light activated antiviral materials and devices and methods for decontaminating virus infected environments